15.6 C
London
Monday, June 27, 2022
- Advertisement -spot_img

CATEGORY

BCAB

Taking Stock of BioAtla’s Risk Factors

BioAtla, Inc. (BCAB) is a global clinical-stage biotechnology company, which focuses on developing Conditionally Active Biologic (CAB) antibody therapeutics. It has three product candidates in...

Latest news

- Advertisement -spot_img